Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Latency arbitrage in blockchain explained. Learn how traders exploit transaction timing, network latency, and MEV in DeFi markets and what it means for Web3.

Discover what an epoch means in cryptocurrency networks, how epochs function in major blockchains like Ethereum and Cardano ...

Knowing what to order on Valentine's Day can be as tricky as snagging a reservation. Cupid says these foods might cause ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

As darkness retreats and flotation tanks gain popularity, a UCSD professor examines how “sensory deprivation” experiments ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Administrators and board members from Evanston/Skokie School District 65 met with parents at Kingsley Elementary School on Tuesday night to discuss ...

Analysis of each side's out-of-possession approaches reveals key differences in philosophies across the division ...

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology ...

Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults and pediatric patients 6 years and older. Arynta ...